Cargando…
A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells
[Image: see text] Hypoxia inducible factor-1 (HIF-1) is a heterodimeric transcription factor that acts as the master regulator of cellular response to reduced oxygen levels, thus playing a key role in the adaptation, survival, and progression of tumors. Here we report cyclo-CLLFVY, identified from a...
Autores principales: | Miranda, Elena, Nordgren, Ida K., Male, Abigail L., Lawrence, Charlotte E., Hoakwie, Franciane, Cuda, Francesco, Court, William, Fox, Keith R., Townsend, Paul A., Packham, Graham K., Eccles, Suzanne A., Tavassoli, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715890/ https://www.ncbi.nlm.nih.gov/pubmed/23796364 http://dx.doi.org/10.1021/ja402993u |
Ejemplares similares
-
Reprogramming the Transcriptional Response to Hypoxia
with a Chromosomally Encoded Cyclic Peptide HIF-1 Inhibitor
por: Mistry, Ishna N., et al.
Publicado: (2016) -
Protein Dynamics of the HIF-2α PAS-B Domain upon Heterodimerization and Ligand Binding
por: Masetti, Matteo, et al.
Publicado: (2014) -
Stable Catechol Keto Tautomers in Cytotoxic Heterodimeric
Cyclic Diarylheptanoids from the Seagrass Zostera marina
por: Li, Yan, et al.
Publicado: (2021) -
A Cytotoxic Heterodimeric Cyclic Diarylheptanoid with
a Rearranged Benzene Ring from the Seagrass Zostera marina
por: Grauso, Laura, et al.
Publicado: (2022) -
Heterodimeric IL-15 in Cancer Immunotherapy
por: Bergamaschi, Cristina, et al.
Publicado: (2021)